|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Nov 30, 2023
|
FY2022
12 months to Nov 30, 2022
|
|
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net income | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Investment income earned on cash and marketable securities held in Trust Account | ||||
| Foreign exchange transaction (gain) loss | ||||
| Loss on equity method investment - related party | ||||
| Gain on disposal of subsidiaries | ||||
| Loss on disposal of subsidiaries | ||||
| Depreciation expense | ||||
| Non-cash lease expense | ||||
| Impairment of convertible note receivable – related party, and equity method investment - related party | ||||
| Share of result of an associate | ||||
| Impairment loss on goodwill | ||||
| Impairment in investment in Joint Venture | ||||
| Unrealized loss on convertible note receivable – related party | ||||
| Impairment of investment in Joint Venture | ||||
| Unrealized loss on convertible note receivable and warrants – related party | ||||
| Fair value loss on marketable securities | ||||
| Loss on disposal of marketable securities | ||||
| Loss on disposal of equipment | ||||
| Impairment loss on equipment | ||||
| Bad debt written off | ||||
| Executive performance share expense | ||||
| Changes in operating assets and liabilities: | ||||
| Other current assets | ||||
| Account receivables | ||||
| Receivable from related party | ||||
| Other receivables | ||||
| Prepaid expenses | ||||
| Deposit | ||||
| Inventory | ||||
| Accounts payable and accrued expenses | ||||
| Accrued commissions | ||||
| Operating lease liabilities | ||||
| Net cash used in operating activities | ||||
| Cash flows from investing activities: | ||||
| Purchases of property and equipment | ||||
| Convertible loans receivable - related party | ||||
| Investment at cost | ||||
| Cash withdrawn from Trust Account for redemptions | ||||
| Cash withdrawn from Trust Account available to the Company | ||||
| Cash deposited into Trust Account | ||||
| Purchase of marketable securities | ||||
| Cash withdrawn from trust account for redemptions | ||||
| Cash withdrawn from trust account available to the Company | ||||
| Deconsolidation of Alset F&B One Pte. Ltd. | ||||
| Loans to related party | ||||
| Net cash (used in) / provided by investing activities | ||||
| Cash flows from financing activities: | ||||
| Proceeds from extension loan | ||||
| Repayment of related party advances | ||||
| Repayment of loans and borrowing | ||||
| Repayment of deferred underwriting compensation | ||||
| Advances from related parties | ||||
| Proceed from brokerage margin and loans | ||||
| Proceed from issuance of Common Stock and Warrants | ||||
| Repayment of Class A Common Stock | ||||
| Repayment of note payable | ||||
| Net cash provided by / (used in) financing activities | ||||
| Net change in cash | ||||
| Net (decrease) increase in cash | ||||
| Effects of foreign exchange rate on cash | ||||
| Cash at beginning of year | ||||
| Cash at end of year | ||||
| Remeasurement of Class A Common Stock subject to redemption | ||||
| Extension funds attributable to common stock subject to redemption | ||||
| Supplemental Cash Flow Information | ||||
| Cash Paid for Interest | ||||
| Cash Paid for Taxes | ||||
| Supplemental disclosure of non-cash investing and financing activities | ||||
| Issuance of HWH common stock to EF Hutton for deferred underwriting compensation | ||||
| Issuance of HWH Common Stock to D. Boral Capital (f.k.a. EF Hutton) for Deferred Underwriting Compensation | ||||
| Issuance of Common Stock for incentive plan 2025 | ||||
| Settlement of deferred underwriting compensation payable with promissory note | ||||
| Debt to equity conversion | ||||
| Valuation gain from notes receivable and warrants - SHRG | ||||
| Initial recognition of operating lease right-of-use asset and liability | ||||
Loading...
